Conventional Total Hip Arthroplasty vs Mako Robotic-arm Assisted Total Hip Arthroplasty

  • End date
    Dec 31, 2022
  • participants needed
  • sponsor
    University College, London
Updated on 6 December 2021
hip arthroplasty
joint reconstruction


The overall aim of this single-centre, prospective randomised controlled trial is to compare clinical, functional, and radiological outcomes in CO THA versus Mako THA. Patients undergoing Mako THA will form the investigation group and those undergoing CO THA will form the control group.

Condition Surgery, Surgical aspects, hip oa, surgeries, surgical procedures, Osteoarthritis, surgical treatment, Arthritis, Arthritis and Arthritic Pain, Arthritis and Arthritic Pain (Pediatric), degenerative arthritis, surgical procedure, Osteoarthritis of hip
Treatment CO THA, Mako THA
Clinical Study IdentifierNCT04095845
SponsorUniversity College, London
Last Modified on6 December 2021


Yes No Not Sure

Inclusion Criteria

Patient has hip osteoarthritis requiring primary THA
Patient and surgeon are in agreement that THA is the most appropriate treatment
Patient is fit for surgical intervention following review by surgeon and anaesthetist
Patient age: Patients 18-80 years of age inclusive
Gender: male and female
Patient must be capable of giving informed consent and agree to comply with the postoperative review program
Patient must be a permanent resident in an area accessible to the study site
Patient must have sufficient postoperative mobility to attend follow-up clinics and allow for radiographs to be taken

Exclusion Criteria

Patient is not suitable for primary THA e.g. patient requires revision surgery for previously failed THA
Patient is not medically fit for surgical intervention
Patients under the age of 18 or over 80 years of age
Patient is immobile or has another neurological condition affecting musculoskeletal function
Patient is already enrolled on another concurrent clinical trial
Patient is unable or unwilling to sign the informed consent form specific to this study
Patient lacks capacity to give informed consent
Patient is unable to attend the follow-up programme
Patient is non-resident in local area or expected to leave the catchment area postoperatively
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note